Repentigny, Canada

Jocelyn Dupuis

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Repentigny, CA (2013 - 2015)
  • Montreal, CA (2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jocelyn Dupuis: Innovator in Medical Treatments

Introduction

Jocelyn Dupuis is a prominent inventor based in Repentigny, Canada. She has made significant contributions to the field of medical treatments, particularly in addressing acute respiratory conditions. With a total of 4 patents to her name, her work has the potential to impact patient care and therapeutic approaches.

Latest Patents

Among her latest patents, one notable invention is focused on methods of treating acute respiratory distress syndrome using colchicine. This patent discloses methods for administering colchicine to subjects in need, showcasing her innovative approach to tackling serious health issues. Another significant patent involves labelled adrenomedullin derivatives and their use for imaging and therapy. This invention relates to adrenomedullin peptides that are chelated or bound to active agents, which can be utilized in Magnetic Resonance Imaging (MRI) and targeted therapies, particularly in the lungs.

Career Highlights

Jocelyn has worked with esteemed organizations such as the Institut De Cardiologie De Montreal and Plumoscience Inc. Her experience in these institutions has allowed her to collaborate on groundbreaking research and development in the medical field.

Collaborations

Throughout her career, Jocelyn has collaborated with notable professionals, including Alain Fournier and Jean-Claude Tardif. These partnerships have contributed to her innovative work and the advancement of medical treatments.

Conclusion

Jocelyn Dupuis stands out as a dedicated inventor whose work in medical treatments is paving the way for new therapeutic options. Her patents reflect her commitment to improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…